GT719 Injection for Moderate to Severe Refractory Autoimmune Disease

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GT719 Injection for Moderate to Severe Refractory Autoimmune Disease	Auto Immune Disease	Recruiting	Early phase 1	2026-04-16		NCT07132112

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Nantong University	71
Grit Biotechnology	19

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Hospital of Nantong University	Nantong	China	14

Clinical trials